C4 Therapeutics
About
C4 Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of medicines for the treatment of cancer and other diseases. They leverage their proprietary drug discovery platform to design and synthesize small molecules that selectively engage the body's protein degradation machinery to target and eliminate disease-causing proteins.
Key facts
At-a-glance profile data
- Website
- c4therapeutics.com
- Headquarters
- Boston, United States
- Founded
- 2016
- Total funding
- $371M (Series D)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 29 Jun 2021 | Series D | $186M | Fidelity Investments |
| 17 Jul 2019 | Series C | $100M | Deerfield Management |
| 29 Mar 2018 | Series B | $70M | - |
| 29 Sept 2016 | Seed | $15M | - |
Tech stack
Detected on c4therapeutics.com, last scanned 19 Sept 2026. Run your own scan
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Mimecast
- Video / media
- Vimeo
- Accessibility
- UserWay
Add first review
Frequently asked
How much funding has C4 Therapeutics raised?
C4 Therapeutics has raised a total of $371M in funding. The most recent round on record is Series D.